Tanezumab: a selective humanized mAb for chronic lower back pain

Michael P Webb1 Department of Anesthesiology, North Shore Hospital, Auckland, New Zealand

Erik M Helander2 Department of Anesthesiology, LSU School of Medicine, New Orleans, LA, USA

Bethany L Menard2 Department of Anesthesiology, LSU School of Medicine, New Orleans, LA, USA

Richard D Urman3 Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USACorrespondence[email protected]

Alan D Kaye2 Department of Anesthesiology, LSU School of Medicine, New Orleans, LA, USA

Pages 361-367 | Published online: 21 Feb 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Centers for Disease Control and Prevention (CDC)Prevalence of disabilities and associated health conditions among adults – United States, 1999MMWR Morb Mortal Wkly Rep200150712012511393491
PubMedGoogle Scholar
SimonJMcAuliffeMShamimFVuongNTahaeiADiscogenic low back painPhys Med Rehabil Clin N Am201425230531724787335
PubMed Web of Science ®Google Scholar
GBD 2015 Disease and Injury Incidence and Prevalence CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet2016388100531545160227733282
PubMed Web of Science ®Google Scholar
FrymoyerJWThe Adult Spine: Principles and PracticePhiladelphia, PALippincott-Raven1997
Google Scholar
CroftPRigbyASBoswellRSchollumJSilmanAThe prevalence of chronic widespread pain in the general populationJ Rheumatol19932047107138496870
PubMed Web of Science ®Google Scholar
RubinDIEpidemiology and risk factors for spine painNeurol Clin200725235337117445733
PubMed Web of Science ®Google Scholar
JarvikJGDeyoRADiagnostic evaluation of low back pain with emphasis on imagingAnn Intern Med2002137758659712353946
PubMed Web of Science ®Google Scholar
LaneNESchnitzerTJBirbaraCAMokhtaraniMSheltonDLSmithMDBrownMTTanezumab for the treatment of pain from osteoarthritis of the kneeN Engl J Med2010363161521153120942668
PubMed Web of Science ®Google Scholar
AbdicheYNMalashockDSPonsJProbing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensorsProtein Sci20081781326133518505735
PubMed Web of Science ®Google Scholar
HallidayDAZettlerCRushRAScicchitanoRMcNeilJDElevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint diseaseNeurochem Res19982369199229572681
PubMed Web of Science ®Google Scholar
ZhaoLRenTHWangDDClinical pharmacology considerations in biologics developmentActa Pharmacol Sin201233111339134723001474
PubMed Web of Science ®Google Scholar
JonssonENXieRMarshallSFArendsRHPopulation pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis painBr J Clin Pharmacol201681468869926613544
PubMed Web of Science ®Google Scholar
PaulWEImmunology: structure and functionPaul WE Fundamental immunology4th edPhiladelphia, PALippencott-Raven1999
Google Scholar
AkileshSHuberTBWuHPodocytes use FcRn to clear IgG from the glomerular basement membraneProc Natl Acad Sci U S A2008105396797218198272
PubMed Web of Science ®Google Scholar
WangDDZhangSZhaoHMenAYParivarKFixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trialsJ Clin Pharmacol20094991012102419620385
PubMed Web of Science ®Google Scholar
United States Food and Drug AdministrationTanezumab Arthritis Advisory Committee Briefing DocumentUSFDA2016 Available from: http://www.fda.gov/downloads/committeesmeetingmaterials/drugs/arthritisadvisorycommittee/ucm295205.pdfAccessed February 4, 2018
Google Scholar
HochbergMCTiveLAAbramsonSBWhen is osteonecrosis not osteonecrosis?: adjudication of reported serious adverse joint events in the Tanezumab Clinical Development ProgramArthritis Rheumatol201668238239126554876
PubMed Web of Science ®Google Scholar
KatzNBorensteinDGBirbaraCBramsonCNemethMASmithMDBrownMTEfficacy and safety of tanezumab in the treatment of chronic low back painPain2011152102248225821696889
PubMed Web of Science ®Google Scholar
KivitzAJGimbelJSBramsonCEfficacy and safety of tanezumab versus naproxen in the treatment of chronic low back painPain201315471009102123628600
PubMed Web of Science ®Google Scholar
GimbelJSKivitzAJBramsonCLong-term safety and effectiveness of tanezumab as treatment for chronic low back painPain201415591793180124937440
PubMed Web of Science ®Google Scholar
LeiteVFBuehlerAMEl AbdOAnti-nerve growth factor in the treatment of low back pain and radiculopathy: a systematic review and a meta-analysisPain Physician2014171E45E6024452657
PubMed Web of Science ®Google Scholar
KnezevicNNMandaliaSRaaschJKnezevicICandidoKDTreatment of chronic low back pain – new approaches on the horizonJ Pain Res2017101111112328546769
PubMed Web of Science ®Google Scholar
BannwarthBKostineMTargeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?Drugs201474661962624691709
PubMed Web of Science ®Google Scholar
PfizerA phase 3 study of tanezumab for chronic low back pain (TANGO) Available from: https://Clinicaltrials.gov/ct2/show/NCT02528253. NLM identifier: NCT02528253Accessed February 4, 2018
Google Scholar
PfizerLong term safety and efficacy study of tanezumab in Japanese adult subjects with chronic low back pain (TANGO) Available from: https://clinicaltrials.gov/ct2/show/record/NCT02725411?term=tanezumab&cond=Chronic+Low-back+Pain&rank=1. NLM identifier: NCT02725411Accessed February 4, 2018
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Tanezumab: a selective humanized mAb for chronic lower back pain

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Tanezumab: a selective humanized mAb for chronic lower back pain

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date